Immuneering Corp
NASDAQ:IMRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
S
|
Swire Pacific Ltd
XBER:SWI
|
HK |
|
N
|
National Bank of Canada
SWB:NBC
|
CA |
|
S
|
State Street Corp
DUS:ZYA
|
US |
|
Roche Holding AG
SIX:RO
|
CH |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
Intel Corp
NASDAQ:INTC
|
US |
|
ArcBest Corp
NASDAQ:ARCB
|
US |
Wall St Price Targets
IMRX Price Targets Summary
Immuneering Corp
According to Wall Street analysts, the average 1-year price target for IMRX is 17.9228 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMRX's stock price target?
Price Target
17.9228
USD
According to Wall Street analysts, the average 1-year price target for IMRX is 17.9228 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.